| About Feet Podiatry Center | |
|
142 John Robert Thomas Dr, The Commons At Lincoln Center, Exton, PA 19341-2656 | |
| (610) 524-3338 | |
| (610) 524-1441 |
| Full Name | About Feet Podiatry Center |
|---|---|
| Type | Facility |
| Speciality | Podiatrist |
| Location | 142 John Robert Thomas Dr, Exton, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114039567 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| About Feet Podiatry Center 142 John Robert Thomas Dr, The Commons At Lincoln Center, Exton, PA 19341-2656 Ph: (610) 524-3338 | About Feet Podiatry Center 142 John Robert Thomas Dr, The Commons At Lincoln Center, Exton, PA 19341-2656 Ph: (610) 524-3338 |
News Archive
Five years after implementing a national initiative to reduce methicillin-resistant Staphylococcus aureus (MRSA) rates in Veterans Affairs (VA) medical centers, MRSA cases have continued to decline, according to a study in the November issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, presented results from preclinical studies with TRX518, an early-stage agent Tolerx is developing as a treatment for cancer. TRX518 is a monoclonal antibody to glucocorticoid-induced tumor necrosis factor receptor (GITR) and is designed to enhance the immune system's ability to attack tumors by activating and rendering T effector cells resistant to T regulatory cell suppression.
Increases in temperatures as a result of climate change is favoring the transmission of the West Nile Virus (WNV) in parts of Europe, by creating more suitable conditions for the virus and its mosquito vectors to proliferate.
An international team of scientists has identified an association between heritable, rare mutations in the RINT1 gene and increased risk of early onset breast cancer, according to research reported today (Oct. 24) at the American Society of Human Genetics 2013 annual meeting in Boston.
In the first thirty days following a heart attack, one in three deaths among patients with signs of heart failure may be preventable by early treatment with a drug called eplerenone (Inspra, Pfizer Ltd), according to new data published in the Journal of the American College of Cardiology (JACC).
› Verified 2 days ago
Dr. Craig T Mchugh, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 142 John Robert Thomas Dr, Exton, PA 19341 Phone: 610-524-3338 Fax: 610-524-1441 | |
Dr. Edward J Piskorski, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 142 John Robert Thomas Dr, Exton, PA 19341 Phone: 610-524-3338 Fax: 610-524-1441 | |
Dr. Priya Sundararajan, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 8 Corbin Dr, Exton, PA 19341 Phone: 314-800-7731 | |
Dr. Timothy Chen, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 684 W Lincoln Hwy, Exton, PA 19341 Phone: 610-269-0800 Fax: 610-269-0510 | |
Dr. Jeffrey E Schneider, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 512 Colfelt Ct, Exton, PA 19341 Phone: 484-875-9355 | |
Dr. Jason S Hearn, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 142 John Robert Thomas Dr, Exton, PA 19341 Phone: 610-524-3338 Fax: 610-524-1441 |